Name: Dopaminergic Neurons
ISBN: 978-1-349-10047-7

Editors:

P. M. Beart⁰,
G. N. Woodruff¹,
D. M. Jackson²

P. M. Beart
1. Clinical Pharmacology and Therapeutics Unit, Austin Hospital, University of Melbourne, Heidelberg, Australia
View editor publications

You can also search for this editor in PubMed Google Scholar
G. N. Woodruff
1. Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, UK
View editor publications

You can also search for this editor in PubMed Google Scholar
D. M. Jackson
1. Department of Pharmacology, University of Sydney, Australia
View editor publications

You can also search for this editor in PubMed Google Scholar

Part of the book series: Satellite Symposia of the Ninth IUPHAR Congress (SSNIC)

9100 Accesses
42 Citations

Buy it now

eBook USD 59.99

Price excludes VAT (USA)

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Learn about institutional subscriptions

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (66 chapters)

Dopamine D-1 and D-2 Receptor-mediated Inhibition and Excitation of Caudate Neurons Induced by Respective High and Low Concentrations of Dopamine in vitro
- Akinori Akaike, Yukihiro Ohno, Masashi Sasa, Shuji Takaori
Pages 131-133
Long-term Apomorphine Produces both Supersensitive and Subsensitive Responses to D1 and D2 Receptor Agonists
- Elisabeth M. Wallis, David M. Jackson, Andrew L. Gundlach, Peter R. Dodd
Pages 134-145
‘Priming’ Phenomena in the Expression of D1 and D2 Receptor Supersensitivity
- M. Morelli, S. Fenu, G. Pomata, G. Di Chiara
Pages 146-148
Regulation of Striatal D1 Dopamine Receptor Density by D1 and D2 Antagonists
- Sally J. Boyson, Paul McGonigle, Perry B. Molinoff
Pages 149-151
Endogenous Dopamine Release from Brain Slices: Comparisons with Radiolabelled Release and Regulation by Autoreceptors
- Hugh Herdon, Stefan R. Nahorski
Pages 152-160
Regulation of Dopamine Release by Muscarinic Receptors
- M. Raiteri, M. Marchi, A. Pittaluga, P. Versace, L. Garbarino
Pages 161-167
Repeated Cocaine Administration Results in Supersensitive Nigrostriatal D-2 Dopamine Autoreceptors
- Nancy R. Zahniser, Joanna Peris, Pamela Curella, Linda P. Dwoskin, Laurie O’Keefe, Sally J. Boyson
Pages 168-174
Functional Presynaptic D-2 and Postsynaptic D-1 Dopamine Receptors in the Central Nervous System
- Margarita L. Dubocovich, Julie G. Hensler
Pages 175-177
Use of Brain Dialysis in Freely Moving Rats for Characterizing the Profile of Dopamine-receptor Agonists
- G. Di Chiara, A. Mulas, A. Imperato
Pages 178-186
Comparison of EMD 38362, (+)3-PPP, (−)3-PPP and BHT 920 in Pre- and Postsynaptic Models for D2-Activity: Discrepancies between in vivo and in vitro Results
- C. A. Seyfried
Pages 187-190
D-1 Agonist Co-treatment Uncovers Postsynaptic Dopamine (DA) Receptor Stimulatory Properties of B-HT 920, a Putative DA (D-2) Autoreceptor-selective Agonist
- Stephan Hjorth, Arvid Carlsson
Pages 191-193
Modulation of the Sensitivity of Synaptosomal Dopamine Autoreceptors to Bromocriptine by in vitro and in vivo Treatments
- Anja H. Tissari, Monica S. Lillgäls
Pages 194-196
Functional Specificity of Nigral Grafts in Dopamine-depleted Rats
- S. B. Dunnett, T. D. Hernandez
Pages 197-203
Genetic and Toxin-induced Depletion of Striatal Dopamine
- Suzanne Roffler-Tarlov, Ann M. Graybiel
Pages 204-210
Functional Significance of Long-term Receptor Hetero-regulation: Further Evidence for Dopaminergic Cortico-subcortical Relationships
- J. P. Tassin, D. Hervé, J. Glowinski
Pages 211-218
Gabaergic Mechanisms after Manipulation of Striatal Dopaminergic Neurons
- Ronald D. Huffman, Maharaj K. Ticku, Joseph M. Frey
Pages 219-225
Inhibition and Excitation Mediated Respectively by Dopamine D-1 and D-2 Receptors on the Caudate Nucleus Neurons Receiving Dopaminergic Input from the Substantia Nigra: Microiontophoretic and in vitro Studies
- Masashi Sasa, Akinori Akaike, Yukihiro Ohno, Yasuhiko Fujita, Shuji Takaori
Pages 226-228
Dopamine-containing Neurons: Intracellular Analysis and Characterization
- Louis A. Chiodo, Gregory Kapatos
Pages 229-235
Lack of Cholinergic Modulation of Mesolimbic Dopamine Function
- Erik B. Nielsen
Pages 236-238
Calcium Antagonists, Neuroleptics and Brain Dopamine
- Bruce I. Diamond, Nick Demartinis, Richard Borison
Pages 239-241

About this book

The proceedings of the 1987 IUPHAR symposium held in Sydney, Australia are fully documented. Over 100 scientists from 16 countries attended the three-day conference, during which time 68 multi-disciplinary presentations concerning dopamine systems and their regulation were made.

Keywords

Editors and Affiliations

Clinical Pharmacology and Therapeutics Unit, Austin Hospital, University of Melbourne, Heidelberg, Australia

P. M. Beart
Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, UK

G. N. Woodruff
Department of Pharmacology, University of Sydney, Australia

D. M. Jackson

Bibliographic Information

Book Title: Dopaminergic Neurons
Editors: P. M. Beart, G. N. Woodruff, D. M. Jackson
Series Title: Satellite Symposia of the Ninth IUPHAR Congress
DOI: https://doi.org/10.1007/978-1-349-10047-7
Publisher: Palgrave Macmillan London
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Palgrave Macmillan, a division of Macmillan Publishers Limited 1988
eBook ISBN: 978-1-349-10047-7Published: 18 June 1988
Series ISSN: 2947-2156
Series E-ISSN: 2947-2164
Edition Number: 1
Number of Pages: XVII, 391
Topics: Pharmacology/Toxicology
Industry Sectors: Biotechnology, Chemical Manufacturing, Consumer Packaged Goods, Health & Hospitals, Pharma

Publish with us

Policies and ethics

Dopaminergic Neurons

Editors:

Sections

Buy it now

Other ways to access

Table of contents (66 chapters)

Dopamine D-1 and D-2 Receptor-mediated Inhibition and Excitation of Caudate Neurons Induced by Respective High and Low Concentrations of Dopamine in vitro

Long-term Apomorphine Produces both Supersensitive and Subsensitive Responses to D1 and D2 Receptor Agonists

‘Priming’ Phenomena in the Expression of D1 and D2 Receptor Supersensitivity

Regulation of Striatal D1 Dopamine Receptor Density by D1 and D2 Antagonists

Endogenous Dopamine Release from Brain Slices: Comparisons with Radiolabelled Release and Regulation by Autoreceptors

Regulation of Dopamine Release by Muscarinic Receptors

Repeated Cocaine Administration Results in Supersensitive Nigrostriatal D-2 Dopamine Autoreceptors

Functional Presynaptic D-2 and Postsynaptic D-1 Dopamine Receptors in the Central Nervous System

Use of Brain Dialysis in Freely Moving Rats for Characterizing the Profile of Dopamine-receptor Agonists

Comparison of EMD 38362, (+)3-PPP, (−)3-PPP and BHT 920 in Pre- and Postsynaptic Models for D2-Activity: Discrepancies between in vivo and in vitro Results

D-1 Agonist Co-treatment Uncovers Postsynaptic Dopamine (DA) Receptor Stimulatory Properties of B-HT 920, a Putative DA (D-2) Autoreceptor-selective Agonist

Modulation of the Sensitivity of Synaptosomal Dopamine Autoreceptors to Bromocriptine by in vitro and in vivo Treatments

Functional Specificity of Nigral Grafts in Dopamine-depleted Rats

Genetic and Toxin-induced Depletion of Striatal Dopamine

Functional Significance of Long-term Receptor Hetero-regulation: Further Evidence for Dopaminergic Cortico-subcortical Relationships

Gabaergic Mechanisms after Manipulation of Striatal Dopaminergic Neurons

Inhibition and Excitation Mediated Respectively by Dopamine D-1 and D-2 Receptors on the Caudate Nucleus Neurons Receiving Dopaminergic Input from the Substantia Nigra: Microiontophoretic and in vitro Studies

Dopamine-containing Neurons: Intracellular Analysis and Characterization

Lack of Cholinergic Modulation of Mesolimbic Dopamine Function

Calcium Antagonists, Neuroleptics and Brain Dopamine

About this book

Keywords

Editors and Affiliations

Clinical Pharmacology and Therapeutics Unit, Austin Hospital, University of Melbourne, Heidelberg, Australia

Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, UK

Department of Pharmacology, University of Sydney, Australia

Bibliographic Information

Publish with us

Buy it now

Other ways to access

Navigation

Editors:

Sections

Buy it now

Buying options

Other ways to access

Table of contents (66 chapters)

About this book

Keywords

Editors and Affiliations

Clinical Pharmacology and Therapeutics Unit, Austin Hospital, University of Melbourne, Heidelberg, Australia

Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, UK

Department of Pharmacology, University of Sydney, Australia

Bibliographic Information

Publish with us

Buy it now

Buying options

Other ways to access

Search

Navigation